These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19309552)

  • 1. Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients.
    Hayashi H; Maeda M; Murakami S; Kumagai N; Chen Y; Hatayama T; Katoh M; Miyahara N; Yamamoto S; Yoshida Y; Nishimura Y; Kusaka M; Fujimoto W; Otsuki T
    Int J Immunopathol Pharmacol; 2009; 22(1):53-62. PubMed ID: 19309552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
    Steen VD; Engel EE; Charley MR; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients.
    Chibowska M; Krasowska D; Weglarz J
    Med Sci Monit; 2001; 7(2):282-8. PubMed ID: 11257736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on cellular immunity in children with respiratory syncytial virus associated acute lower respiratory infection].
    Chen Z; Dong Y; Zhang M; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):263-6. PubMed ID: 15617344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].
    Wang Z; Li D; Yang J
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):439-41. PubMed ID: 9387297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Clin Exp Rheumatol; 1996; 14(4):413-6. PubMed ID: 8871841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
    Simsek H; Kadayifci A
    J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
    Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M
    Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers.
    Sun A; Chu CT; Liu BY; Wang JT; Leu JS; Chiang CP
    Proc Natl Sci Counc Repub China B; 2000 Jul; 24(3):116-22. PubMed ID: 10943944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients.
    Wu P; Miura Y; Hyodoh F; Nishimura Y; Hatayama T; Hatada S; Sakaguchi H; Kusaka M; Katsuyama H; Tomita M; Otsuki T
    Int J Immunopathol Pharmacol; 2006; 19(2):357-68. PubMed ID: 16831302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlations of T lymphocyte subsets and IL-2, sIL-2R in patients with malignant ovarian tumor].
    Wang H; Peng Z; Zhang C
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):210-3. PubMed ID: 10683937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.